A brief review of pharmacotherapies for smoking cessation

Research output: Contribution to journalShort surveypeer-review

4 Scopus citations

Abstract

The U.S. Department of Health and Human Services' Clinical Practice Guidelines have established both nicotine and nonnicotine-based pharmacotherapies as efficacious treatments for smoking cessation. Smokers attempting to quit smoking can significantly increase their chances by using one of several first-line agents, including nicotine transdermal patches, gum, nasal spray, inhalers, tablets, and the antidepressant bupropion. Those who cannot use either bupropion or nicotine replacement therapy because of contraindications or lack of effectiveness may benefit from the second-line treatment nortriptyline. This article also discusses several novel compounds for smoking cessation.

Original languageEnglish (US)
Pages (from-to)583-589
Number of pages7
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume4
Issue number6
DOIs
StatePublished - Jul 2006

Keywords

  • Antidepressant
  • Nicotine replacement treatment
  • Pharmacotherapy
  • Smoking cessation

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'A brief review of pharmacotherapies for smoking cessation'. Together they form a unique fingerprint.

Cite this